<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK263441" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK263441/" /><meta name="ncbi_pagename" content="ADCY5-Related Dyskinesia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>ADCY5-Related Dyskinesia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="ADCY5-Related Dyskinesia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/12/17" /><meta name="citation_author" content="Chris Shaw" /><meta name="citation_author" content="Fuki Hisama" /><meta name="citation_author" content="Jennifer Friedman" /><meta name="citation_author" content="Thomas D Bird" /><meta name="citation_pmid" content="25521004" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK263441/" /><meta name="citation_keywords" content="Familial Dyskinesia with Facial Myokymia (FDFM)" /><meta name="citation_keywords" content="Familial Benign Chorea" /><meta name="citation_keywords" content="Adenylate cyclase type 5" /><meta name="citation_keywords" content="ADCY5" /><meta name="citation_keywords" content="ADCY5-Related Dyskinesia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="ADCY5-Related Dyskinesia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Chris Shaw" /><meta name="DC.Contributor" content="Fuki Hisama" /><meta name="DC.Contributor" content="Jennifer Friedman" /><meta name="DC.Contributor" content="Thomas D Bird" /><meta name="DC.Date" content="2015/12/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK263441/" /><meta name="description" content="ADCY5-related dyskinesia is characterized by infantile to late-adolescent onset of paroxysmal choreiform, myoclonic, and/or dystonic movements that involve the limbs, neck, and/or face. Dyskinesias are often exacerbated by anxiety (although not by startle, caffeine, or alcohol). Facial &quot;twitches&quot; (previously thought to be myokymia) involving the periorbital and/or perioral muscles may also be present. Hypotonia and delayed motor milestones may be present in more severely affected infants. The movement disorder can be static or slowly progressive, with a tendency to stabilize in early middle age. Intellect and life span are normal." /><meta name="og:title" content="ADCY5-Related Dyskinesia" /><meta name="og:type" content="book" /><meta name="og:description" content="ADCY5-related dyskinesia is characterized by infantile to late-adolescent onset of paroxysmal choreiform, myoclonic, and/or dystonic movements that involve the limbs, neck, and/or face. Dyskinesias are often exacerbated by anxiety (although not by startle, caffeine, or alcohol). Facial &quot;twitches&quot; (previously thought to be myokymia) involving the periorbital and/or perioral muscles may also be present. Hypotonia and delayed motor milestones may be present in more severely affected infants. The movement disorder can be static or slowly progressive, with a tendency to stabilize in early middle age. Intellect and life span are normal." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK263441/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/adcy5-dysk/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK263441/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AFD22E03FC7110000000007CC02AA.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK263441_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK263441_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/adamtsl4-eyes/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/adnp-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK263441_"><span class="title" itemprop="name"><i>ADCY5</i>-Related Dyskinesia</span></h1><p class="contrib-group"><span itemprop="author">Chris Shaw</span>, BS, <span itemprop="author">Fuki Hisama</span>, MD, <span itemprop="author">Jennifer Friedman</span>, MD, and <span itemprop="author">Thomas D Bird</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK263441_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK263441_ai__"><div class="contrib half_rhythm"><span itemprop="author">Chris Shaw</span>, BS<div class="affiliation small">School of Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@43src" class="oemail">ude.wu@43src</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Fuki Hisama</span>, MD<div class="affiliation small">Division of Medical Genetics<br />Department of Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@2hmf" class="oemail">ude.wu@2hmf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jennifer Friedman</span>, MD<div class="affiliation small">Departments of Neuroscience and Pediatrics<br />University of California, San Diego<br />San Diego, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.dshcr@namdeirfrj" class="oemail">gro.dshcr@namdeirfrj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Thomas D Bird</span>, MD<div class="affiliation small">Seattle VA Medical Center<br />Departments of Neurology and Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@zornmot" class="oemail">ude.wu@zornmot</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 18, 2014</span>; Last Revision: <span itemprop="dateModified">December 17, 2015</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="adcy5-dysk.Summary" itemprop="description"><h2 id="_adcy5-dysk_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>ADCY5</i>-related dyskinesia is characterized by infantile to late-adolescent onset of paroxysmal choreiform, myoclonic, and/or dystonic movements that involve the limbs, neck, and/or face. Dyskinesias are often exacerbated by anxiety (although not by startle, caffeine, or alcohol). Facial "twitches" (previously thought to be myokymia) involving the periorbital and/or perioral muscles may also be present. Hypotonia and delayed motor milestones may be present in more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants. The movement disorder can be static or slowly progressive, with a tendency to stabilize in early middle age. Intellect and life span are normal.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a hyperkinetic movement disorder in the absence of structural brain abnormalities and confirmed by the detection of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ADCY5.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Anecdotally, medications have had variable effect in suppressing debilitating symptoms. Treatment trials should be determined by the individual's physician, taking into account potential risk/benefit, other medical conditions, allergies, and potential drug-drug interactions. Response to medication is difficult to evaluate because some patients have long periods (weeks) of remission of the dyskinesia.</p><p><i>Prevention of secondary complications:</i> Physical and occupational therapy may help maintain mobility and function.</p><p><i>Surveillance:</i> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are reevaluated annually (or more frequently if medication trials are undertaken) to document disease progression and determine if other interventions are necessary.</p><p><i>Agents/circumstances to avoid:</i> Known triggers (anxiety and stress) and possible triggers (intercurrent illness, prolonged inactivity, fatigue, and excitement).</p><p><i>Pregnancy management:</i> Potential teratogenic effects of medications given for treatment of dyskinesias should be discussed with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women of childbearing age, ideally prior to conception.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>ADCY5</i>-related dyskinesia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. <i>De novo</i> mutation has been reported. Each child of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 50% chance of inheriting the <i>ADCY5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal testing for pregnancies at increased risk is possible if the <i>ADCY5</i> pathogenic variant has been identified in an affected family member.</p></div></div><div id="adcy5-dysk.GeneReview_Scope"><h2 id="_adcy5-dysk_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="adcy5-dysk.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK263441/table/adcy5-dysk.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adcy5-dysk.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adcy5-dysk.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>ADCY5</i>-Related Dyskinesia: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_adcy5-dysk.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Familial dyskinesia with facial myokymia (FDFM)</div></li><li class="half_rhythm"><div>Familial benign chorea</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#adcy5-dysk.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="adcy5-dysk.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes, see <a href="#adcy5-dysk.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="adcy5-dysk.Diagnosis"><h2 id="_adcy5-dysk_Diagnosis_">Diagnosis</h2><p>There are no current published guidelines for the diagnosis of <i>ADCY5</i>-related dyskinesia.</p><div id="adcy5-dysk.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Diagnosis of <i>ADCY5</i>-related dyskinesia <b>should be suspected</b> in individuals with:</p><ul><li class="half_rhythm"><div>Infantile to late-adolescent onset of paroxysmal choreiform, myoclonic, and/or dystonic movements that involve the limbs, neck, and/or face;</div></li><li class="half_rhythm"><div>No evidence of structural abnormalities on brain MRI.</div></li></ul></div><div id="adcy5-dysk.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>ADCY5</i>-related dyskinesia <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a hyperkinetic movement disorder in the absence of structural brain abnormalities and confirmed by the detection of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ADCY5</i> (see <a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTmoleculargenetictestingu" rid-ob="figobadcy5dyskTmoleculargenetictestingu">Table 1</a>).</p><p>Approaches to <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> are the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Sequence analysis of <i>ADCY5</i>.</b> No deletions or duplications in <i>ADCY5</i> associated with dyskinesia have been reported thus far. To date, only 15 persons representing <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> (i.e., a single occurrence in a family) cases and members of five families have been proven to have <i>ADCY5</i>-related dyskinesia (see <a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.confirmed_familial_and_simp/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTconfirmedfamilialandsimp" rid-ob="figobadcy5dyskTconfirmedfamilialandsimp">Table 2</a>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ADCY5</i> and other genes of interest (see <a href="#adcy5-dysk.Differential_Diagnosis">Differential Diagnosis</a>). Note: The genes included and the methods used in multigene panels vary by laboratory and are likely to change over time.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="adcy5-dysk.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>ADCY5</i>-Related Dyskinesia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK263441/table/adcy5-dysk.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adcy5-dysk.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adcy5-dysk.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_adcy5-dysk.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_adcy5-dysk.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_adcy5-dysk.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADCY5</i></td><td headers="hd_h_adcy5-dysk.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_adcy5-dysk.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/7&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_adcy5-dysk.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_adcy5-dysk.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="adcy5-dysk.TF.1.1"><p class="no_margin">See <a href="/books/NBK263441/#adcy5-dysk.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#adcy5-dysk.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="adcy5-dysk.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="adcy5-dysk.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#adcy5-dysk.REF.chen.2011.1252">Chen et al [2011]</a>, <a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al [2014]</a>, <a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al [2015]</a>, YZ Chen [personal observation]</p></div></dd><dt>4. </dt><dd><div id="adcy5-dysk.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd></dl></div></div></div></div></div><div id="adcy5-dysk.Clinical_Characteristics"><h2 id="_adcy5-dysk_Clinical_Characteristics_">Clinical Characteristics</h2><div id="adcy5-dysk.Clinical_Description"><h3>Clinical Description</h3><p>Thus far, only 15 individuals representing <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> (i.e., a single occurrence in a family) cases and members of seven families with <i>ADCY5</i>-related dyskinesia have been reported [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2011.1252">Chen et al 2011</a>; <a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>; YZ Chen, personal observation]. Therefore, the phenotypic spectrum of this disorder is still being elucidated. Affected individuals identified to date have overlapping but not identical clinical manifestations with wide-ranging clinical severity.</p><p><b>Neurologic manifestations.</b> All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date have had episodes of choreiform, myoclonic, and/ or dystonic movements that primarily affect the limbs, face, and/or neck. Typically the abnormal movements first appear during infancy, childhood, or early adolescence (range: neonatal period to age 19 years) [<a class="bk_pop" href="#adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</a>].</p><p>In those with milder manifestations, the abnormal movements involve the face and distal limbs and (although minimally affecting function) are socially debilitating. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may be described as "excessively clumsy."</p><p>In those with more severe manifestations, the hypotonia or movement disorder can interfere with activities of daily living. For example, proximal adventitious movements and/or weakness and hypotonia may affect the ability to ambulate, requiring the use of wheelchairs.</p><p>The abnormal movements are continual during waking hours, and have been noted to persist during sleep, particularly in infancy. Several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have noted severe, sleep-disrupting movements [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>; <a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>; YZ Chen, personal observation], which occurred during stages N2 and N3 of sleep and were not associated with epileptiform discharges in one individual [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>].</p><p>A curious feature observed in some individuals is the occurrence of long periods (days to weeks) of remission.</p><p>The movements are often exacerbated by anxiety (although not by startle, caffeine, or alcohol). Some report that episodes are more frequent in the morning or when tired. One woman reported that her choreiform movements were precipitated by enforced inactivity (e.g., as during a road trip), and could often be alleviated by voluntary movement.</p><p>Facial "twitches" (previously thought to be myokymia) involving the periorbital and/or perioral muscles may also be present. Twitches were also documented in limb muscles in one individual [<a class="bk_pop" href="#adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</a>].</p><p>Hypotonia and delayed motor milestones may be present in more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants.</p><p>Dysarthria and hypotonia have been reported in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>, <a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>, <a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</a>].</p><p>Neurologic examination can vary widely between individuals and in the same individual over time. Examination may reveal:</p><ul><li class="half_rhythm"><div>A mixed movement disorder that may include prominent choreiform movements usually affecting the hands and/or feet, often characterized as piano playing movements;</div></li><li class="half_rhythm"><div>Myoclonic and dystonic movements;</div></li><li class="half_rhythm"><div>Non-myokymic facial twitching, hyperreflexia of the lower limbs, and intermittent head or limb tremors [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>];</div></li><li class="half_rhythm"><div>Axial hypotonia with limb and axial weakness including severe neck weakness [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>; <a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>; YZ Chen, personal observation].</div></li></ul><p>The natural history varies. In most, the abnormal movements are static or slowly progressive with increased severity and frequency. In some cases, choreiform movements have been more constant, and less paroxysmal, from onset [<a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</a>]. The overall tendency is for the abnormal movements to stabilize in early middle age, at which point they may improve in some.</p><p>Intellect and life span are normal in individuals with <i>ADCY5-</i>related dyskinesia.</p><p><b>Cardiac complications.</b>
<a class="bk_pop" href="#adcy5-dysk.REF.chen.2011.1252">Chen et al [2011]</a> reported that five individuals in a family with <i>ADCY5-</i>related dyskinesia also had congestive heart failure. Because <i>ADCY5</i> encodes a specific adenylyl cyclase that is highly expressed in both striatum and myocardium [<a class="bk_pop" href="#adcy5-dysk.REF.matsuoka.1997.498">Matsuoka et al 1997</a>], these observations suggest that mutation of <i>ADCY5</i> could contribute to cardiac pathology; further study is required.</p><p><b>Studies</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Needle electromyogram (EMG)</b> in two individuals with facial muscle twitching initially revealed what was thought to be myokymia (see Note) [<a class="bk_pop" href="#adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</a>]; however, subsequent EMG studies in the same individuals suggested centrally driven irregular muscle movements that were also observed in other muscles, including the orbicularis oculi, tongue, frontalis, and dorsal interosseus muscles. No fibrillations, fasciculations, myokymia, or myotonia were noted on EMG.</div><div class="half_rhythm">Note: Myokymia is clinically characterized by a localized, fine, rippling motion of muscles under the skin; it can be differentiated from other causes of involuntary muscle movements more precisely by EMG.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Neuroimaging.</b> Brain MRI in all reported <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals has been normal.</div><div class="half_rhythm">SPECT imaging in one patient showed nonspecific slight hypo-perfusion in the temporal lobes, right-sided basal ganglia, and right cerebellar hemisphere [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>].</div></li></ul></div><div id="adcy5-dysk.Pathophysiology"><h3>Pathophysiology</h3><p>The mechanism underlying neurologic dysfunction and dyskinesias has not been clearly delineated yet. In <i>ADCY5</i>-related dyskinesia, the changes seen in adenylyl cyclase V have been shown to increase intracellular cAMP, which could exert a myriad of effects at the cellular level [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>].</p></div><div id="adcy5-dysk.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlation</h3><p>Currently, the number of patients and families tested is too small to make reliable predictions of phenotypic features based on <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> (<a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.confirmed_familial_and_simp/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTconfirmedfamilialandsimp" rid-ob="figobadcy5dyskTconfirmedfamilialandsimp">Table 2</a>).</p><div id="adcy5-dysk.T.confirmed_familial_and_simp" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Confirmed Familial and Simplex Cases of <i>ADCY5</i>-Related Dyskinesia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK263441/table/adcy5-dysk.T.confirmed_familial_and_simp/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adcy5-dysk.T.confirmed_familial_and_simp_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" style="text-align:left;vertical-align:middle;">Familial or Simplex Case</th><th id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features</th><th id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" style="text-align:left;vertical-align:middle;"><i>ADCY5</i> Variant</th><th id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" style="text-align:left;vertical-align:middle;">Citation</th></tr><tr><th headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2" id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Dyskinesia</th><th headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2" id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Facial Twitching</th><th headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2" id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypotonia</th></tr></thead><tbody><tr><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.adcy5_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTadcy5pathogenicvariantsd" rid-ob="figobadcy5dyskTadcy5pathogenicvariantsd">p.Ala726Thr</a></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#adcy5-dysk.REF.chen.2011.1252">Chen et al [2011]</a></td></tr><tr><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Simplex&#x000a0;<sup>1</sup></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.adcy5_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTadcy5pathogenicvariantsd" rid-ob="figobadcy5dyskTadcy5pathogenicvariantsd">p.Arg418Trp</a></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al [2014]</a></td></tr><tr><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Simplex&#x000a0;<sup>1</sup></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.adcy5_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTadcy5pathogenicvariantsd" rid-ob="figobadcy5dyskTadcy5pathogenicvariantsd">p.Arg418Trp</a></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al [2014]</a></td></tr><tr><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.adcy5_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTadcy5pathogenicvariantsd" rid-ob="figobadcy5dyskTadcy5pathogenicvariantsd">p.Ala726Thr</a></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al [2015]</a></td></tr><tr><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.adcy5_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTadcy5pathogenicvariantsd" rid-ob="figobadcy5dyskTadcy5pathogenicvariantsd">p.Met1029Lys</a></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al [2015]</a></td></tr><tr><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.adcy5_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTadcy5pathogenicvariantsd" rid-ob="figobadcy5dyskTadcy5pathogenicvariantsd">p.Arg418Trp</a></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al [2015]</a></td></tr><tr><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Simplex</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK263441/table/adcy5-dysk.T.adcy5_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figadcy5dyskTadcy5pathogenicvariantsd" rid-ob="figobadcy5dyskTadcy5pathogenicvariantsd">p.Arg418Trp</a></td><td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al [2015]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="adcy5-dysk.TF.2.1"><p class="no_margin">In the two individuals who represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases, mutation of <i>ADCY5</i> occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</p></div></dd></dl></div></div></div><p>Additional cases with confirmed <i>ADCY5</i> pathogenic variants are reported in <a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al [2015]</a>.</p><p>Of note, the two <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases with documented <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants had more severe phenotypes than those with inherited pathogenic variants [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>].</p><p>One person who improved considerably during adulthood was shown to be mosaic for the variant p.Met1029Lys [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>]. A second individual, thought to be mosaic for p.Arg418Trp, exhibited significantly milder phenotypic features: with fewer facial twitches, milder chorea, and no dysarthria [<a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</a>].</p></div><div id="adcy5-dysk.Penetrance"><h3>Penetrance</h3><p>In the few documented cases of <i>ADCY5</i> dyskinesia, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> has been 100% in both men and women.</p></div><div id="adcy5-dysk.Nomenclature"><h3>Nomenclature</h3><p><i>ADCY5</i>-related dyskinesia has been previously described as:</p><ul><li class="half_rhythm"><div>A variant of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> essential ("benign") chorea [<a class="bk_pop" href="#adcy5-dysk.REF.bird.1976.357">Bird et al 1976</a>, <a class="bk_pop" href="#adcy5-dysk.REF.bird.1978.271">Bird &#x00026; Hall 1978</a>]. Although the term "benign" was used to distinguish the movement disorder from progressive, neurodegenerative forms of chorea such as <a href="/books/n/gene/huntington/">Huntington disease</a>, <i>ADCY5</i>-related dyskinesia can be disabling and in some instances progressive, and, thus, use of the term "benign hereditary chorea" should be avoided.</div></li><li class="half_rhythm"><div>"Familial dyskinesia facial myokymia" because the prominent facial twitching was originally thought to be myokymia (see <a href="#adcy5-dysk.Clinical_Description">Clinical Description</a>); however, more recently EMG studies of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have revealed that these twitches are not myokymia.</div></li></ul><p>DYT-<i>ADCY5</i> may be an appropriate designation because dystonia is often a prominent feature [<a class="bk_pop" href="#adcy5-dysk.REF.marras.2012.1016">Marras et al 2012</a>].</p></div><div id="adcy5-dysk.Prevalence"><h3>Prevalence</h3><p>There are no data available for the prevalence of <i>ADCY5-</i>related dyskinesia.</p><p>To date, <i>ADCY5</i> pathogenic variants have been found to segregate with the disease in three unrelated families, each with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in three or more generations (18 in 1 family, 11 in the 2nd family, and 4 in the 3rd family) and in four additional smaller families. <i>ADCY5</i> pathogenic variants have been identified in two <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) [<a class="bk_pop" href="#adcy5-dysk.REF.bird.1976.357">Bird et al 1976</a>, <a class="bk_pop" href="#adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</a>, <a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>, <a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>].</p><p><i>ADCY5-</i>related dyskinesia is probably underrecognized.</p></div></div><div id="adcy5-dysk.Genetically_Related_Allelic_D"><h2 id="_adcy5-dysk_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>ADCY5.</i></p></div><div id="adcy5-dysk.Differential_Diagnosis"><h2 id="_adcy5-dysk_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="/books/n/gene/dystonia-ov/">Dystonia Overview</a>.</p><p><a href="/books/n/gene/huntington/">Huntington disease</a>, a progressive, neurodegenerative, fatal disorder characterized by motor, cognitive, and psychiatric disturbances, can be differentiated from <i>ADCY5</i>-related dyskinesia by: mean age of onset of Huntington disease (35 to 44 years); and presence of choreiform movements that become constant over time.</p><p>Benign hereditary chorea (BHC) (OMIM <a href="http://omim.org/entry/118700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">118700</a>) is a relatively rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition caused by mutation of <i>NKX2-1</i>. BHC presents before age five years; however, in contrast to <i>ADCY5</i>-related dyskinesia, symptoms often improve by late adolescence [<a class="bk_pop" href="#adcy5-dysk.REF.bird.1978.271">Bird &#x00026; Hall 1978</a>]. Non-neurologic manifestations have been seen in both disorders; mutation of <i>NKX2-1</i> has been associated with pulmonary symptoms and endocrine abnormalities, most commonly hypothyroidism, while <i>ADCY5</i> pathogenic variants have rarely coincided with cardiac dysfunction [<a class="bk_pop" href="#adcy5-dysk.REF.inzelberg.2011.301">Inzelberg et al 2011</a>].</p><p><a href="/books/n/gene/prrt2-parox/">Familial paroxysmal kinesigenic dyskinesia</a> (PKD) is characterized by unilateral or bilateral involuntary movements precipitated by other sudden movements such as standing up from a sitting position, being startled, or changes in velocity; attacks include combinations of dystonia, choreoathetosis, and ballism; are sometimes preceded by an aura; and do not involve loss of consciousness. Unlike <i>ADCY5</i>-related dyskinesia, PKD is more common in men and is precipitated by voluntary movement. PKD is caused by mutation of <i>PRRT2</i>, encoding proline-rich transmembrane protein 2 [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2011.1252">Chen et al 2011</a>, <a class="bk_pop" href="#adcy5-dysk.REF.wang.2011.3493">Wang et al 2011</a>].</p><p><a href="/books/n/gene/pnknd/">Familial paroxysmal nonkinesigenic dyskinesia</a> (PNKD) is characterized by unilateral or bilateral involuntary movements; attacks are spontaneous or precipitated by alcohol, chocolate, coffee or tea, excitement, stress, or fatigue. Attacks involve dystonic posturing with choreic and ballistic movements, may be accompanied by a preceding aura, occur while the individual is awake, and are not associated with seizures. Unlike the episodes in <i>ADCY5</i>-related dyskinesia, these episodes may be precipitated by consumption of alcohol or caffeine. In some families, PNKD is caused by mutation of <i>PNKD,</i> encoding probable hydrolase PNKD [<a class="bk_pop" href="#adcy5-dysk.REF.rainier.2004.1025">Rainier et al 2004</a>].</p><p><a href="/books/n/gene/glut1/">Paroxysmal choreoathetosis/spasticity</a> (DYT9) presents with dystonic paroxysms affecting the toes, legs, and arms; dysarthria; and changes in perioral sensation, sometimes accompanied by headache. This disorder is caused by mutation of <i>SLC2A1</i> leading to a defect in GLUT1 (also known as glucose transporter type 1 deficiency syndrome) [<a class="bk_pop" href="#adcy5-dysk.REF.weber.2011.959">Weber et al 2011</a>].</p><p>Tardive dyskinesia, a hyperkinetic movement disorder associated with long-term use of specific dopamine receptor blocking agents (including neuroleptics and certain antiemetics) [<a class="bk_pop" href="#adcy5-dysk.REF.aquino.2014.s113">Aquino &#x00026; Lang 2014</a>], is often precipitated by a recent dose reduction or a change to a less potent drug.</p><p>Sydenham chorea, a manifestation of acute rheumatic fever, is the most common cause of acquired chorea in childhood, and typically presents between ages five and 12 years. Although carditis and arthritis are other manifestations of rheumatic fever, chorea may be the only clinical sign. Antistreptolysin O (ASO) titers are elevated in a significant proportion of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p>Multiple sclerosis can cause continuous facial myokymia in individuals with lesions impinging on the facial nerve as it courses in the dorsolateral pontine tegmentum. Other features &#x02013; particularly abnormalities on brain MRI, which are disseminated in space and time &#x02013; should assist in making the correct diagnosis.</p><p><a href="/books/n/gene/mt-overview/">Mitochondrial disorders</a> can present with dystonia or other abnormal movements.</p><p>Neurotransmitter disorders include <a href="/books/n/gene/drd/">GTP cyclohydolase deficiency</a>, which results in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> dystonia with a dramatic response to treatment with L-dopa.</p><p>The hyperkinetic movements of <i>ADCY5</i>-related dyskinesia may be mistakenly thought to be epileptiform; however, normal EEGs, lack of impaired consciousness, and/or lack of response to antiepileptic medication distinguish epilepsy from <i>ADCY5</i>-related dyskinesia.</p></div><div id="adcy5-dysk.Management"><h2 id="_adcy5-dysk_Management_">Management</h2><div id="adcy5-dysk.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>ADCY5</i>-related dyskinesia, the following are recommended:</p><ul><li class="half_rhythm"><div>Neurologic consultation with particular attention to documenting the findings on neurologic examination, and response or lack of response to medications</div></li><li class="half_rhythm"><div>Consideration of cardiac evaluation, as cardiomyopathy may be a manifestation of <i>ADCY5</i>-related dyskinesia [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2011.1252">Chen et al 2011</a>]</div></li><li class="half_rhythm"><div>Social services consultation (depending on the severity of the paroxysms), as disease severity may qualify some patients for disability or social security benefits</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="adcy5-dysk.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Medication</b> has been variably effective in suppressing debilitating symptoms. Treatment trials should be determined by the individual's physician, taking into account potential risk/benefit, other medical conditions, allergies, and potential drug-drug interactions. Response to medication is difficult to evaluate in an individual because some patients have long periods (weeks) of remission of the dyskinesia.</p><ul><li class="half_rhythm"><div><b>Acetazolamide,</b> which induces a mild alkalosis, has been shown previously to improve the dyskinesia [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>]. In one individual 15 mg/kg/day completely alleviated episodes of dyskinesia for an extended, but non-sustained, period of time [<a class="bk_pop" href="#adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</a>].</div></li><li class="half_rhythm"><div><b>Propanolol,</b> which has suppressed dyskinesia in other disorders (including essential tremor, <a href="/books/n/gene/prrt2-parox/">paroxysmal kinesigenic dyskinesia</a>, and <a href="/books/n/gene/ea1/">episodic ataxia type 1</a>), has had variable success in <i>ADCY5</i>-related dyskinesia.</div></li><li class="half_rhythm"><div><b>Levetiracetam,</b> an anti-convulsant, helped decrease the severity of adventitious movements in one patient [T Bird, personal observation; J Friedman, personal observation].</div></li><li class="half_rhythm"><div><b>Tetrabenazine,</b> which has been used as a symptomatic treatment for other hyperkinetic disorders, resulted in subjective symptom improvement in two patients [<a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</a>; FM Hisama, personal observation].</div></li><li class="half_rhythm"><div><b>Benzodiazepines,</b> which have been used in symptomatic treatment for other hyperkinetic disorders, have been associated with variable improvement in <i>ADCY5</i>-related dyskinesia [J Friedman, personal observation].</div></li><li class="half_rhythm"><div><b>Trihexylphenidyl,</b> an antimuscarinic compound used in treating Parkinson disease, was observed to decrease the intensity and frequency of episodes of dyskinesia in one patient, when paired with tetrabenazine [<a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</a>].</div></li></ul><p>Of note, little to no improvement was observed after administration of primidone, chlordiazepoxide, amitriptyline, trifluoperazine, trihexylphenidyl, vitamin C, coenzyme Q<sub>10</sub>, carbamazepine, and valproic acid.</p><p><b>Stress management.</b> The only exacerbating factor that is observed consistently across <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is the presence of anxiety and exposure to typical life stressors. Further investigation is needed to determine whether stress management techniques or limitation of stressful activities may reduce the number and frequency of movements.</p></div><div id="adcy5-dysk.Prevention_of_Secondary_Compl"><h3>Prevention of Secondary Complications</h3><p>Physical and occupational therapy may assist patients in maintaining mobility and function.</p></div><div id="adcy5-dysk.Surveillance"><h3>Surveillance</h3><p>There are no published guidelines for surveillance. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are reevaluated in neurology clinics and/ or clinical genetics clinics annually (or more frequently if medication trials are undertaken) to document disease progression and determine if other interventions are necessary.</p></div><div id="adcy5-dysk.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>All patients have reported that anxiety and stress worsen disease manifestations.</p><p>Less commonly reported triggers include intercurrent illness, prolonged inactivity, fatigue, and excitement.</p></div><div id="adcy5-dysk.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#adcy5-dysk.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="adcy5-dysk.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Potential teratogenic effects of medications given for treatment of <i>ADCY5</i>-related dyskinesia should be discussed with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women of childbearing age, ideally prior to conception.</p></div><div id="adcy5-dysk.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="adcy5-dysk.Genetic_Counseling"><h2 id="_adcy5-dysk_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="adcy5-dysk.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>ADCY5</i>-related dyskinesia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="adcy5-dysk.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">Some individuals diagnosed with <i>ADCY5</i>-related dyskinesia have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>ADCY5</i>-related dyskinesia may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>]. The proportion of <i>ADCY5</i>-related dyskinesia caused by a <i>de novo</i> pathogenic variant is currently unknown, as molecular genetic data are insufficient. When neither parent of a proband with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the <i>ADCY5</i> pathogenic variant or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>.</div></li><li class="half_rhythm"><div class="half_rhythm">If the <i>ADCY5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent and a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div class="half_rhythm">Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include a detailed clinical and family history with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of both parents if the pathogenic variant has been identified in the proband.</div></li><li class="half_rhythm"><div class="half_rhythm">The family history of some individuals diagnosed with <i>ADCY5</i>-related dyskinesia may appear to be negative because of failure to recognize the disorder in family members, or mild/late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>) have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div><div class="half_rhythm">Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has the <i>ADCY5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of the proband is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>If the <i>ADCY5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent resulting in more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>ADCY5</i>-related dyskinesia has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents. If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="adcy5-dysk.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the <i>ADCY5</i> pathogenic variant or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="adcy5-dysk.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ADCY5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <i>ADCY5</i>-related dyskinesia are possible.</p></div></div><div id="adcy5-dysk.Resources"><h2 id="_adcy5-dysk_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Dystonia Medical Research Foundation</b></div><div>One East Wacker Drive</div><div>Suite 1730</div><div>Chicago IL 60601-1905</div><div><b>Phone:</b> 800-377-3978 (toll-free); 312-755-0198</div><div><b>Fax:</b> 312-803-0138</div><div><b>Email:</b> dystonia@dystonia-foundation.org</div><div><a href="https://dystonia-foundation.org/what-is-dystonia/types-dystonia/paroxysmal/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Paroxysmal Dyskinesias</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/gene/ADCY5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADCY5-associated dyskenesia</a></div></li></ul></div><div id="adcy5-dysk.Molecular_Genetics"><h2 id="_adcy5-dysk_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="adcy5-dysk.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>ADCY5-Related Dyskinesia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK263441/table/adcy5-dysk.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adcy5-dysk.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_adcy5-dysk.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_adcy5-dysk.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_adcy5-dysk.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_adcy5-dysk.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_adcy5-dysk.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_adcy5-dysk.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/111" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ADCY5</i></a></td><td headers="hd_b_adcy5-dysk.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=111" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_adcy5-dysk.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O95622" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Adenylate cyclase type 5</a></td><td headers="hd_b_adcy5-dysk.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ADCY5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADCY5</a></td><td headers="hd_b_adcy5-dysk.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ADCY5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADCY5</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="adcy5-dysk.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="adcy5-dysk.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for ADCY5-Related Dyskinesia (<a href="/omim/600293,606703" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK263441/table/adcy5-dysk.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adcy5-dysk.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600293" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600293</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADENYLATE CYCLASE 5; ADCY5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606703" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606703</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>ADCY5</i> consists of 21 exons spanning 173.25 kb. Transcript <a href="/nuccore/NM_183357.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_183357.2</a> is 6098 bp in length and encodes the isoform <a href="/protein/NP_899200.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_899200.1</a>. A shorter alternative transcript <a href="/nuccore/NM_001199642.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001199642.1</a> has a different 5' untranslated region and is missing a portion of the 5' <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>. A functional difference has not been assigned to this structural change or to the shorter isoform that it encodes. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK263441/#adcy5-dysk.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> No benign variants of clinical significance have been documented in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of <i>ADCY5</i>.</p><p><b>Pathogenic variants.</b> The variant c.2176G&#x0003e;A (p.Ala726Thr) was identified as an inherited change in a large German American family [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2012.630">Chen et al 2012</a>] and later detected in another multigenerational family of English American ancestry [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>]. The variant c.1252C&#x0003e;T (p.Arg418Trp) was identified as a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> change in two separate families [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>] and more recently shown to be a recurrent <i>do novo</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ADCY5</i>-related dyskinesia [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>]. A different <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant, c.1253G&#x0003e;A (Arg418Gln), has also been repeatedly found in <i>de novo</i> cases [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>]. The pathogenic variant p.Met1029Lys has been identified in a single three-generation family [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</a>]. A French father and son with chorea and dystonia and a c.2088+1G&#x0003e;A variant affecting a donor <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> were recently reported [<a class="bk_pop" href="#adcy5-dysk.REF.carapito.2015.423">Carapito et al 2015</a>]. No RNA was detected from the mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, and ADCY5 RNA concentration was half that in normal controls. The authors postulated <i>ADCY5</i> haploinsuffiency as the mechanism, in contrast to the <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism demonstrated for missense variants [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>]. This finding is not consistent with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>Adcy5</i>-knockout mice, which have normal motor function [<a class="bk_pop" href="#adcy5-dysk.REF.iwamoto.2003.16936">Iwamoto et al 2003</a>]. The effect of pathogenic variants on signaling in the striatum of humans remains unclear.</p><div id="adcy5-dysk.T.adcy5_pathogenic_variants_d" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>ADCY5</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK263441/table/adcy5-dysk.T.adcy5_pathogenic_variants_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adcy5-dysk.T.adcy5_pathogenic_variants_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1252C&#x0003e;T</td><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg418Trp</td><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_183357.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_183357<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_899200.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_899200<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2176G&#x0003e;A</td><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala726Thr</td></tr><tr><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3086T&#x0003e;A</td><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met1029Lys</td></tr><tr><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1253G&#x0003e;A</td><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg418Gln</td></tr><tr><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2088+1G&#x0003e;A</td><td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The normal product of <i>ADCY5</i> is the adenylyl cyclase type V protein (ADCY5). The longest isoform of ADCY5 (<a href="/protein/NP_899200.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_899200.1</a>) consists of 1261 amino acid residues, which are organized into four domains: two 6-helical section transmembrane regions and two cytosolic catalytic regions [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>].</p><p>The adenylyl cyclase <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> family encodes a number of proteins that convert adenosine triphosphate (ATP) to cyclic adenosine-3',5'-monophosphate (cAMP), a second messenger molecule that exerts a wide variety of effects via a number of intracellular signaling pathways [<a class="bk_pop" href="#adcy5-dysk.REF.buck.1999.79">Buck et al 1999</a>]. ADCY5 is one of nine different membrane-bound adenylyl cyclases, and converts adenosine triphosphate (ATP) to cyclic adenosine-3',5'-monophosphate (cAMP). It is highly expressed in myocardium and striatum [<a class="bk_pop" href="#adcy5-dysk.REF.matsuoka.1997.498">Matsuoka et al 1997</a>]. ADCY5 is especially prevalent in the nucleus accumbens, accounting for 80% of adenylate cyclase activation [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2011.1252">Chen et al 2011</a>]. Stimulation of ADCY5 by &#x003b2;-adrenergic agonists through a G-protein-coupled receptor induces a conformational change, aligning the two cytoplasmic domains such that they form a catalytic pocket in which ATP can bind [<a class="bk_pop" href="#adcy5-dysk.REF.whisnant.1996.6621">Whisnant et al 1996</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The c.2176G&#x0003e;A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurs in the region of the gene encoding the S6 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the transmembrane domain (M1) and the c.1252C&#x0003e;T pathogenic variant occurs in the first catalytic domain (C1b) [<a class="bk_pop" href="#adcy5-dysk.REF.chen.2014.542">Chen et al 2014</a>]. These two pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variants which are hypothesized to increase ADCY5 activity by affecting either the signal transduction pathway following &#x003b2;-adrenergic stimulation or the interaction of the protein with other regulatory molecules. The expression of the c.1252C&#x0003e;T variant has been shown to progressively increase during the first 500 days post conception in striatal tissue [<a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</a>].</p></div><div id="adcy5-dysk.References"><h2 id="_adcy5-dysk_References_">References</h2><div id="adcy5-dysk.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.aquino.2014.s113">Aquino CC, Lang AE. Tardive dyskinesia syndromes: current concepts. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2014;<span class="ref-vol">20</span> Suppl 1:S113–7.</span> [<a href="/pubmed/24262160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24262160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.bird.1976.357">Bird TD, Carlson CB, Hall JG. Familial essential ("benign") chorea. <span><span class="ref-journal">J Med Genet. </span>1976;<span class="ref-vol">13</span>:357–62.</span> [<a href="/pmc/articles/PMC1013440/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1013440</span></a>] [<a href="/pubmed/1003446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1003446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.bird.1978.271">Bird TD, Hall JG. Additional information on familial essential (benign) chorea. <span><span class="ref-journal">Clin Genet. </span>1978;<span class="ref-vol">14</span>:271–2.</span> [<a href="/pubmed/152174" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 152174</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.buck.1999.79">Buck J, Sinclair ML, Schapal L, Cann MJ, Levin LR. Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1999;<span class="ref-vol">96</span>:79–84.</span> [<a href="/pmc/articles/PMC15096/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC15096</span></a>] [<a href="/pubmed/9874775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9874775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.carapito.2015.423">Carapito R, Paul N, Untrau M, Le Gentil M, Ott L, Alsaleh G, Jochem P, Radosavljevic M, Le Caignec C, David A, Darnier P, Isidor B, Bahram S. A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia. <span><span class="ref-journal">Movement Dis. </span>2015;<span class="ref-vol">30</span>:423–7.</span> [<a href="/pubmed/25545163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25545163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.chen.2015.2026">Chen DH, M&#x000e9;neret A, Friedman JR, Korvatska O, Gad A, Bonkowski ES, Stessman HA, Doummar D, Mignot C, Anheim M, Bernes S, Davis MY, Damon-Perri&#x000e8;re N, Degos B, Grabli D, Gras D, Hisama FM, Mackenzie KM, Swanson PD, Tranchant C, Vidailhet M, Trouillard O, Amendola LM, Dorschner MO, Weiss M, Eichler EE, Winesett S, Torkamani A, Roze E, Bird TD, Raskind WH. ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:2026–35.</span> [<a href="/pmc/articles/PMC4676753/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4676753</span></a>] [<a href="/pubmed/26537056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26537056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.chen.2011.1252">Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH, Guo SL, He J, Chen YF, Zhang QJ, Li HF, Lin Y, Murong SX, Xu J, Wang N, Wu ZY. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:1252–5.</span> [<a href="/pubmed/22101681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22101681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.chen.2014.542">Chen YZ, Friedman JR, Chen DH, Chan GC, Bloss CS, Hisama FM, Topol SE, Carson AR, Pham PH, Bonkowski ES, Scott ER, Lee JK, Zhang G, Oliveira G, Xu J, Scott-Van Zeeland AA, Chen Q, Levy S, Topol EJ, Storm D, Swanson PD, Bird TD, Schork NJ, Raskind WH, Torkamani A. Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">75</span>:542–9.</span> [<a href="/pmc/articles/PMC4457323/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4457323</span></a>] [<a href="/pubmed/24700542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24700542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.chen.2012.630">Chen YZ, Matsushita MM, Robertson P, Rieder M, Girirajan S, Antonacci F, Lipe H, Eichler EE, Nickerson DA, Bird TD, Raskind WH. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. <span><span class="ref-journal">Arch Neurol. </span>2012;<span class="ref-vol">69</span>:630–5.</span> [<a href="/pmc/articles/PMC3508680/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3508680</span></a>] [<a href="/pubmed/22782511" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22782511</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.fernandez.2001.486">Fernandez M, Raskind W, Wolff J, Matsushita M, Yuen E, Graf W, Lipe H, Bird T. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:486–92.</span> [<a href="/pubmed/11310626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11310626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.inzelberg.2011.301">Inzelberg R, Weinberger M, Gak E. Benign hereditary chorea: An update. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2011;<span class="ref-vol">17</span>:301–7.</span> [<a href="/pubmed/21292530" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21292530</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.iwamoto.2003.16936">Iwamoto T, Okumura S, Iwatsugo K, Kawabe J, Ohtsu K, Sakai I, Hashimoto Y, Izumitani A, Sango K, Ajiki K, Toya Y, Umemura S, Goshima Y, Arai N, Vatner S, Ishikawa Y. Motor dysfunction in Type 5 adenylyl cyclase-null mice. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:16936–40.</span> [<a href="/pubmed/12665504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12665504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.marras.2012.1016">Marras C, Lohmann K, Lang A, Klein C. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:1016–24.</span> [<a href="/pmc/articles/PMC3310311/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3310311</span></a>] [<a href="/pubmed/22454269" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22454269</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.matsuoka.1997.498">Matsuoka I, Suzuki Y, Defer N, Nakanishi H, Hanoune J. Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. <span><span class="ref-journal">J Neurochem. </span>1997;<span class="ref-vol">68</span>:498–506.</span> [<a href="/pubmed/9003034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9003034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.mencacci.2015.80">Mencacci NE, Erro R, Wiethoff S, Hersheson J, Ryten M, Balint B, Ganos C, Stamelou M, Quinn N, Houlden H, Wood NW, Bhatia KP. ADCY5 mutations are another cause of benign hereditary chorea. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:80–8.</span> [<a href="/pmc/articles/PMC4501937/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4501937</span></a>] [<a href="/pubmed/26085604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26085604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.rainier.2004.1025">Rainier S, Thomas D, Tokarz D, Ming L, Bui M, Plein E, Zhao X, Lemons R, Albin R, Delaney C, Alvarado D, Fink JK. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. <span><span class="ref-journal">Arch Neurol. </span>2004;<span class="ref-vol">61</span>:1025–9.</span> [<a href="/pubmed/15262732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15262732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.wang.2011.3493">Wang JL, Cao L, Li XH, Hu ZM, Li JD, Zhang JG, Liang Y. San-A, Li N, Chen SQ, Guo JF, Jiang H, Shen L, Zheng L, Mao X, Yan WQ, Zhou Y, Shi YT, Ai SX, Dai MZ, Zhang P, Xia K, Chen SD, Tang BS. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. <span><span class="ref-journal">Brain. </span>2011;<span class="ref-vol">134</span>:3493–501.</span> [<a href="/pmc/articles/PMC3235563/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3235563</span></a>] [<a href="/pubmed/22120146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22120146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.weber.2011.959">Weber YG, Kamm C, Suls A, Kempfle J, Kotschet K, Sch&#x000fc;le R, Wuttke TV, Maljevic S, Liebrich J, Gasser T, Ludolph AC, Van Paesschen W, Sch&#x000f6;ls L, De Jonghe P, Auburger G, Lerche H. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">77</span>:959–64.</span> [<a href="/pubmed/21832227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21832227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adcy5-dysk.REF.whisnant.1996.6621">Whisnant RE, Gilman AG, Dessauer CW. Interaction of the two cytosolic domains of mammalian adenylyl cyclase. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1996;<span class="ref-vol">93</span>:6621–5.</span> [<a href="/pmc/articles/PMC39075/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC39075</span></a>] [<a href="/pubmed/8692867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8692867</span></a>]</div></li></ul></div></div><div id="adcy5-dysk.Chapter_Notes"><h2 id="_adcy5-dysk_Chapter_Notes_">Chapter Notes</h2><div id="adcy5-dysk.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 December 2015 (fh) Revision: addition of data from <a class="bk_pop" href="#adcy5-dysk.REF.chen.2015.2026">Chen et al [2015]</a> and <a class="bk_pop" href="#adcy5-dysk.REF.mencacci.2015.80">Mencacci et al [2015]</a></div></li><li class="half_rhythm"><div>18 December 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>29 August 2014 (fh) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK263441</span><span class="label">PMID: <a href="/pubmed/25521004" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">25521004</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/adamtsl4-eyes/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/adnp-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK263441&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK263441/?report=reader">PubReader</a></li><li><a href="/books/NBK263441/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK263441" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK263441" style="display:none" title="Cite this Page"><div class="bk_tt">Shaw C, Hisama F, Friedman J, et al. ADCY5-Related Dyskinesia. 2014 Dec 18 [Updated 2015 Dec 17]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK263441/pdf/Bookshelf_NBK263441.pdf">PDF version of this page</a> (196K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#adcy5-dysk.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#adcy5-dysk.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#adcy5-dysk.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#adcy5-dysk.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#adcy5-dysk.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#adcy5-dysk.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#adcy5-dysk.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#adcy5-dysk.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#adcy5-dysk.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#adcy5-dysk.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#adcy5-dysk.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#adcy5-dysk.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=111[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ADCY5</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3320148" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3320148" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3320148" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3320148" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24700542" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.</a><span class="source">[Ann Neurol. 2014]</span><div class="brieflinkpop offscreen_noflow">Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen YZ, Friedman JR, Chen DH, Chan GC, Bloss CS, Hisama FM, Topol SE, Carson AR, Pham PH, Bonkowski ES, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Neurol. 2014 Apr; 75(4):542-9. Epub 2014 Mar 13.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26537056" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations.</a><span class="source">[Neurology. 2015]</span><div class="brieflinkpop offscreen_noflow">ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen DH, Méneret A, Friedman JR, Korvatska O, Gad A, Bonkowski ES, Stessman HA, Doummar D, Mignot C, Anheim M, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurology. 2015 Dec 8; 85(23):2026-35. Epub 2015 Nov 4.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234941" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gertler T, Bearden D, Bhattacharjee A, Carvill G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=25521004" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=25521004" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041075dd21425a2592c29b">ADCY5-Related Dyskinesia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">ADCY5-Related Dyskinesia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:44:21-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AFD22E03FC7110000000007CC02AA&amp;ncbi_session=CE8AFD22E0410741_1996SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK263441%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK263441&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK263441/&amp;ncbi_pagename=ADCY5-Related Dyskinesia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AFD22E0410741_1996SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>